The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

Simmons & Simmons

Work +44 20 7628 2020
Fax +44 20 7628 2070

Michael Gavey

Work 020 7825 4625
Simmons & Simmons

Work Department

Intellectual property.


Michael specialises in all types of transactions involving intellectual property. He has considerable experience in a wide range of industry sectors, including life sciences, TMT, energy and financial institutions. He advises regularly on licensing and collaboration agreements, as well as related commercial arrangements. He assists with sales of shares and assets sales, and financings, where intellectual property is involved. Michael also specialises in life sciences regulatory law, advising on issues, agreements and disputes concerning biobanks, clinical trials, marketing authorisation, manufacturing, distribution, promotion and pharmacovigilance.


Qualified 2002; partner 2012; secondment to GlaxoSmithKline and Castrol. He is the author of numerous articles and has spoken at conferences on a variety of topical intellectual property and regulatory issues, including recently on M&A considerations in licensing deals, borderline products, personalised medicines, clinical trials and social media.


Degree in genetics; Diploma in IP Law and Practice 2003.

London: TMT (technology, media and telecoms)

Intellectual property

Within: Intellectual property

The 'excellent' and 'commercially astute' practice at Simmons & Simmons attracts praise for its 'fantastic legal and technical knowledge' and capabilities in national and international disputes and transactions, particularly in the healthcare, life sciences and technology, media and telecoms sectors. Practice head Michael Gavey is a healthcare and life sciences sector expert, while Angus McLean focuses on the fintech industry. Other names to note include patent litigators Michael Burdon, Richard Binns and Andrew Hutchinson; Scott Parker, who frequently acts for pharmaceutical and biotechnology companies, and Darren Meale, who 'is well-versed in UK and EU trade mark law'.

[back to top]

Pharmaceuticals and biotechnology

Within: Pharmaceuticals and biotechnology

The Simmons & Simmons healthcare and life sciences group is headed by Michael Gavey (together with Alexandre Regniault  in Paris). Its client roster ranges from major pharmaceutical and medical device and biotech companies to healthcare operators and charities such as the Institute of Cancer Research. Gavey also heads the IP team and digital health group and assists clients with IP-related transactions, regulatory regimes and compliance. Michael Burdon and Scott Parker deal with patent litigation, often involving multiple jurisdictions. Charles Mayo is a corporate partner who advises on a wide range of commercial and finance matters. Associate Lydia Torne is noted for her IP transactional and regulatory compliance work involving a range of healthcare products.

[back to top]

Back to index

Legal Developments by:
Simmons & Simmons

  • Failure to counter financial crime: Norwich Union Life

    In December 2007, the Financial Services Authority (FSA) imposed a fine of £1.26m on Norwich Union Life (part of the Aviva Group), one of the largest life insurance businesses in the UK with around seven million customers. The fine related to failures to take reasonable care to establish and maintain effective systems and controls for countering the risks of financial crime. The fine is the latest confirmation of the emphasis being placed on protecting clients and customers from the threat of financial crime.
    - Simmons & Simmons

Legal Developments in London

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to